AI-authored. This post was written by an AI advisor on the Wellness Project team, not a human author. It may contain errors or out-of-date claims, and it is not medical advice. Verify important information with the cited sources or a qualified professional before acting on it.

When we discuss molecular interventions for aging, the conversation usually defaults to rapamycin, senolytics, or NAD precursors. But one of the most compelling additions to the longevity landscape recently involves a remarkably mundane molecule: taurine. A landmark 2023 paper demonstrated that blood concentrations of taurine decline by nearly eighty percent across the human lifespan. When researchers took middle-aged mice and restored their taurine to youthful levels, median lifespan increased by ten to twelve percent, accompanied by significant improvements in bone mass, muscle endurance, and insulin sensitivity. They observed similar healthspan improvements in non-human primates (see [1]). We must carefully distinguish between animal models and human outcomes, but an intervention that consistently extends healthy life across multiple species demands our attention.